Proshares Nanotechnology Etf Number Of Employees
| TINY Etf | USD 46.68 0.69 1.46% |
ProShares Nanotechnology ETF fundamentals help investors to digest information that contributes to ProShares Nanotechnology's financial success or failures. It also enables traders to predict the movement of ProShares Etf. The fundamental analysis module provides a way to measure ProShares Nanotechnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ProShares Nanotechnology etf.
ProShares |
ProShares Nanotechnology ETF ETF Number Of Employees Analysis
ProShares Nanotechnology's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current ProShares Nanotechnology Number Of Employees | 7 |
Most of ProShares Nanotechnology's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ProShares Nanotechnology ETF is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
| Competition |
Based on the recorded statements, ProShares Nanotechnology ETF is currently employing 7.0 people. This is much higher than that of the ProShares family and significantly higher than that of the Technology category. The number of employees for all United States etfs is notably lower than that of the firm.
ProShares Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ProShares Nanotechnology's direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of ProShares Nanotechnology could also be used in its relative valuation, which is a method of valuing ProShares Nanotechnology by comparing valuation metrics of similar companies.ProShares Nanotechnology is currently under evaluation in number of employees as compared to similar ETFs.
Fund Asset Allocation for ProShares Nanotechnology
The fund invests 99.7% of asset under management in tradable equity instruments, with the rest of investments concentrated in various types of exotic instruments.Asset allocation divides ProShares Nanotechnology's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
ProShares Fundamentals
| Return On Asset | -0.03 | |||
| Profit Margin | (22.08) % | |||
| Operating Margin | (263.42) % | |||
| Current Valuation | 51.56 M | |||
| Shares Outstanding | 31.17 M | |||
| Shares Owned By Insiders | 7.58 % | |||
| Shares Owned By Institutions | 31.90 % | |||
| Number Of Shares Shorted | 305.45 K | |||
| Price To Earning | (2.45) X | |||
| Price To Book | 0.50 X | |||
| Price To Sales | 22.42 X | |||
| Revenue | 917 K | |||
| Gross Profit | 917 K | |||
| Net Income | (20.25 M) | |||
| Cash And Equivalents | 17.92 M | |||
| Cash Per Share | 0.43 X | |||
| Total Debt | 5 M | |||
| Debt To Equity | 0.07 % | |||
| Current Ratio | 22.20 X | |||
| Cash Flow From Operations | (6.53 M) | |||
| Earnings Per Share | (0.53) X | |||
| Beta | 1.62 | |||
| Market Capitalization | 40.18 M | |||
| Total Asset | 1.92 M | |||
| Retained Earnings | (123.29 M) | |||
| Working Capital | 16.41 M | |||
| Current Asset | 18.88 M | |||
| Current Liabilities | 2.47 M | |||
| One Year Return | 21.00 % | |||
| Three Year Return | 5.40 % | |||
| Net Asset | 1.92 M | |||
| Equity Positions Weight | 99.70 % |
About ProShares Nanotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ProShares Nanotechnology ETF's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ProShares Nanotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ProShares Nanotechnology ETF based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out ProShares Nanotechnology Piotroski F Score and ProShares Nanotechnology Altman Z Score analysis. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
The market value of ProShares Nanotechnology is measured differently than its book value, which is the value of ProShares that is recorded on the company's balance sheet. Investors also form their own opinion of ProShares Nanotechnology's value that differs from its market value or its book value, called intrinsic value, which is ProShares Nanotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProShares Nanotechnology's market value can be influenced by many factors that don't directly affect ProShares Nanotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProShares Nanotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProShares Nanotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProShares Nanotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.